October 16, 2021

applebusiness

We Build Business

Butterfly Community Announces Critical Appointments to the Board and Management

GUILFORD, Conn. & NEW YORK–(Business enterprise WIRE)–Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), an ground breaking digital wellness firm that is operating to democratize professional medical imaging and add to the aspiration of world-wide well being equity, currently declared the growth of its Board of Administrators to nine directors by means of the appointment of Dr. Erica Schwartz and the addition of Troy Quander to the leadership staff as Senior Vice President, Regulatory and Quality. These appointments keep on to bolster the specialized basis of the organization to assure that it can effectively execute its mission of democratizing medical imaging and advancing clinical observe all over the world.

“Dr. Schwartz will add depth and functionality to the Board of Directors with her encounter handling health care organizations, coupled with her background in medication, biomedical engineering and legislation,” reported Dr. Todd Fruchterman. Her addition to our Board will be notably valuable, in areas of clinical purposes, engineering progress, and strategy.”

Dr. Schwartz brings a breadth of health care administration and general public well being experience to the Butterfly Board of Directors. She served as the Deputy Surgeon Basic for the U.S. Office of Overall health and Human Products and services from March 2019 to April 2021, the place she led the country’s general public well being deployment in reaction to the COVID-19 pandemic. Prior to her function as the Deputy Surgeon General, Dr. Schwartz spent 24 years in the uniformed service, through which time she was promoted via the ranks to Rear Admiral of the U.S. Coast Guard, wherever she served as the Main Professional medical Officer and Director of Overall health, Security, and Work Everyday living from 2015 to 2019. Beforehand, Dr. Schwartz served as the U.S. Coast Guard’s Main of Health and fitness Expert services from 2013 to 2015 and Preventive Medicine Chief from 2005 to 2013. Dr. Schwartz has served on the Board of Administrators of Aveanna Healthcare Holdings Inc. (Nasdaq: AVAH), a company of a broad array of pediatric and grownup health care companies, given that May possibly 2021.

Dr. Schwartz is educated, and board licensed in preventive medicine. She gained a Bachelor of Science degree in Biomedical Engineering from Brown College, a Clinical Doctorate from Brown University Faculty of Medicine, a Master of Public Health diploma with a dual focus in health products and services administration and occupational and environmental drugs from the Uniformed Companies University of the Wellbeing Sciences, and a Juris Doctorate from the College of Maryland University of Regulation.

Dr. Schwartz will provide on the newly shaped Board Technological know-how Committee, along with Dr. Rothberg and Dr. Edelman, giving oversight of the job of technological innovation in executing Butterfly’s tactic and supporting business and operational requirements.

“Butterfly is a leader in healthcare imaging and effectively positioned to travel variations in scientific apply with differentiated engineering and answers,” Dr. Schwartz mentioned. “I am honored to be part of the Butterfly Board of Administrators to be a portion of its mission to renovate care all close to the world.”

In addition, Butterfly announces the appointment of Troy Quander as Senior Vice President, Regulatory and High-quality for Butterfly powerful September 13, 2021. In this freshly created government place, Troy will lead the mixed regulatory, high-quality, and article market surveillance teams supporting the potential technique to satisfy the requires of the company’s scaling enterprise. Troy will report to Dr. Todd Fruchterman, President and CEO of Butterfly Community, Inc. and will be a member of the Butterfly’s Government Leadership Group.

“Regulatory and top quality are essential capabilities pivotal to Butterfly’s achievements in advancing care delivery by way of the use of ultrasound information,” stated Dr. Todd Fruchterman. “We are really energized to provide on a seasoned chief like Troy with the breadth and depth of expertise that will assistance us convey additional innovative alternatives to sector in a well timed manner.”

Troy is a regulatory expert with about 25 years of Foods and Drug Administration (Food and drug administration) and field encounter with a emphasis on regulatory affairs, regulatory compliance, and excellent. He joins Butterfly from Olympus, wherever he was the Vice President of Regulatory Affairs, and responsible for world regulatory strategy advancement and execution for the clinical product organization segment. Prior to Olympus, Troy held important management roles for regulatory affairs and excellent for Roche Diagnostics. In addition, he held prior management roles of raising obligation at Becton Dickinson, OraSure Technologies, Johnson & Johnson, and bioMerieux. Troy put in component of his vocation with the FDA’s Middle for Biologics Evaluation and Exploration, as a merchandise reviewer and products expert for Group Biologics, the place he performed submission assessments of in vitro diagnostics and carried out facility inspections. He holds a bachelor’s degree in Biology from Lincoln University.

“I am thrilled to be part of the Butterfly crew. It is an inspiring firm with an modern, high-progress vision. I glance forward to doing work with Todd and the Butterfly group to condition our foreseeable future in a way that is compliant and adheres to the evolving rules of the medical system business,” reported Mr. Quander.

At this fascinating time in the company’s journey, Butterfly welcomes Dr. Schwartz and Mr. Quander to a passionate group committed to its mission, vision, and technological innovation.

About Butterfly Community, Inc.

Started by Dr. Jonathan Rothberg in 2011 and not long ago listed on the NYSE by way of a merger with Longview Acquisition Corp, Butterfly created the world’s very first handheld, single probe full-entire body ultrasound procedure, Butterfly iQ. Butterfly’s mission is to permit common accessibility to excellent health-related imaging, producing higher-high-quality ultrasound affordable, straightforward-to-use, globally accessible, and intelligently connected, which include for the 4.7 billion individuals all over the entire world lacking entry to ultrasound. By way of its proprietary Ultrasound-on-Chip™ know-how, Butterfly is paving the way for previously detection and distant administration of overall health ailments close to the world. The Butterfly iQ can be ordered on the internet currently by healthcare practitioners in the United States, Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Eire, Italy, the Netherlands, New Zealand, Norway, Poland, Portugal, Spain, Sweden, Switzerland, and the United Kingdom.

Ahead Seeking Statements

This push release contains “forward-hunting statements” inside of the that means of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. The Company’s true success may possibly vary from its expectations, estimates, and projections and, therefore, you must not depend on these forward-hunting statements as predictions of long term events. Terms this sort of as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and related expressions (or the adverse variations of these phrases or expressions) are meant to establish these types of forward-hunting statements. These ahead-searching statements include things like, devoid of limitation, the Company’s expectations with respect to future general performance and progress of merchandise and providers. These ahead-wanting statements entail substantial threats and uncertainties that could lead to the genuine results to differ materially from all those talked over in the ahead-on the lookout statements. Most of these variables are exterior the Company’s management and are hard to forecast. Aspects that may possibly lead to this kind of variations incorporate, but are not minimal to: the affect of COVID-19 on the Company’s enterprise the capability to realize the expected positive aspects of the business enterprise blend the Company’s skill to mature and manage progress profitably the results, expense and timing of the Company’s product and service growth functions the likely characteristics and advantages of the Company’s products and solutions and services the Company’s ability to attain and sustain regulatory approval for its products, and any linked restrictions and limits of any authorised product or service the Company’s means to identify, in-license or receive extra technological innovation the Company’s potential to maintain its current license, manufacture, provide and distribution agreements the Company’s capacity to compete with other businesses at this time advertising or engaged in the improvement of solutions and expert services that the Business is at this time advertising or developing improvements in applicable regulations or polices the measurement and expansion prospective of the markets for the Company’s products and providers, and its skill to serve people markets, both by itself or in partnership with some others the pricing of the Company’s products and solutions and expert services and reimbursement for healthcare strategies carried out using its items and companies the Company’s estimates relating to bills, profits, funds specifications and demands for more financing the Company’s fiscal efficiency the Company’s skill to raise funding in the long run and other challenges and uncertainties indicated from time to time in the Company’s filings with the Securities and Exchange Fee. The Business cautions that the foregoing checklist of things is not distinctive. The Company cautions you not to spot undue reliance upon any forward-seeking statements, which discuss only as of the day of this press release. The Enterprise does not undertake or accept any obligation or undertake to release publicly any updates or revisions to any ahead-seeking statements to mirror any modify in the Company’s anticipations or any alter in gatherings, ailments or instances on which any these types of statement is based mostly.